BIOL Stock - BIOLASE, Inc.
Unlock GoAI Insights for BIOL
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|
| Revenue | $49.16M | $48.46M | $39.19M | $22.78M | $37.80M |
| Gross Profit | $16.72M | $15.91M | $16.53M | $6.17M | $14.29M |
| Gross Margin | 34.0% | 32.8% | 42.2% | 27.1% | 37.8% |
| Operating Income | $-17,937,000 | $-25,338,000 | $-16,116,000 | $-18,536,000 | $-15,621,000 |
| Net Income | $-20,632,000 | $-28,634,000 | $-16,158,000 | $-16,829,000 | $-17,855,000 |
| Net Margin | -42.0% | -59.1% | -41.2% | -73.9% | -47.2% |
| EPS | $-16.14 | $-413.19 | $-273.41 | $-688.19 | $-1923.95 |
BIOLASE, Inc., together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, such as cosmetic, restorative, and complex surgical applications. The company offers Waterlase all-tissue dental laser systems for cutting soft and hard tissues; diode soft-tissue laser systems for soft tissue, pain therapy, teeth whitening, and cosmetic procedures; and Epic Hygiene laser to manage non-surgical periodontitis and enhance clinical production. It also manufactures and sells consumable products and accessories for its laser systems, as well as markets flexible fibers and hand pieces, and teeth whitening gel kits. The company sells its products through its field sales force and distributor network. The company was formerly known as BIOLASE Technology, Inc. and changed its name to BIOLASE, Inc. in 2012. BIOLASE, Inc. was founded in 1984 and is headquartered in Foothill Ranch, California.
Visit WebsiteEarnings History & Surprises
BIOLEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q3 2025 | Aug 6, 2025 | — | — | — | — |
Q2 2025 | May 12, 2025 | — | — | — | — |
Q1 2025 | Mar 19, 2025 | — | — | — | — |
Q4 2024 | Nov 7, 2024 | $-0.06 | — | — | — |
Q3 2024 | Aug 8, 2024 | $-0.07 | $-0.08 | -14.3% | ✗ MISS |
Q2 2024 | May 13, 2024 | $-0.17 | $-0.36 | -111.8% | ✗ MISS |
Q1 2024 | Mar 21, 2024 | $-2.56 | $-1.76 | +31.3% | ✓ BEAT |
Q4 2023 | Nov 9, 2023 | $-1.85 | $-3.89 | -110.3% | ✗ MISS |
Q3 2023 | Aug 10, 2023 | $-5.33 | $-8.93 | -67.5% | ✗ MISS |
Q2 2023 | May 11, 2023 | $-0.20 | $-18.00 | -8900.0% | ✗ MISS |
Q1 2023 | Mar 28, 2023 | $0.64 | $-128.00 | -20100.0% | ✗ MISS |
Q4 2022 | Nov 10, 2022 | $-0.84 | $-110.00 | -12995.2% | ✗ MISS |
Q3 2022 | Aug 11, 2022 | $-0.62 | $-91.00 | -14577.4% | ✗ MISS |
Q2 2022 | May 12, 2022 | $-0.68 | $-81.00 | -11811.8% | ✗ MISS |
Q1 2022 | Mar 17, 2022 | $-75.00 | $-75.00 | 0.0% | = MET |
Q4 2021 | Nov 10, 2021 | $-75.00 | $-50.00 | +33.3% | ✓ BEAT |
Q3 2021 | Aug 12, 2021 | $-100.00 | $-50.00 | +50.0% | ✓ BEAT |
Q2 2021 | May 13, 2021 | $-125.00 | $-150.00 | -20.0% | ✗ MISS |
Q1 2021 | Mar 25, 2021 | $-100.00 | $-175.00 | -75.0% | ✗ MISS |
Q4 2020 | Nov 12, 2020 | $-150.00 | $-525.00 | -250.0% | ✗ MISS |
Latest News
Frequently Asked Questions about BIOL
What is BIOL's current stock price?
What is the analyst price target for BIOL?
What sector is BIOLASE, Inc. in?
What is BIOL's market cap?
Does BIOL pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to BIOL for comparison